
585 Sedighi, M., Pourmoghaddam Qhazvini, P. and Amidpour, M. (2023) ‘Algae-Powered Buildings:
A Review of an Innovative, Sustainable Approach in the Built Environment’. Sustainability, 15(4).
https://doi.org/10.3390/su15043729
586 Karacaoğlu, B., İnan, B. and Balkanlı Özçimen, D. (2023) ‘Microfluidic systems as a novel
approach for microalgal bioprocess’. Biochemical. Engineering Journal, 197. http://dx.doi.
org/10.1016/j.bej.2023.108959
587 Heins, A., Hoang, M. D., and Weuster-Botz, D. (2021) ‘Advances in automated real-time flow
cytometry for monitoring of bioreactor processes.’ Engineering in Life Sciences, 22(3–4):
260–278. https://doi.org/10.1002/elsc.202100082
588 Delgado, C.F., Ferretti, M.T. and Carnevale, A. (2024) ‘Chapter 9 - Beyond one-size-fits-all: Pre-
cision medicine and novel technologies for sex- and gender-inclusive COVID-19 pandemic man-
agement’. Innovating Health Against Future Pandemics, 2024: 133–156. https://doi.org/10.1016/
B978-0-443-13681-8.00012-6
589 Su, J. et al. (2024) ‘Personalized Drug Therapy: Innovative Concept Guided With Proteoformics’.
Molecular and Cellular Proteomics MCP, 23(3). https://doi.org/10.1016/j.mcpro.2024.100737
590 The Health Foundation (2023) ‘NHS figures show health service under considerable strain’. 13
April. www.health.org.uk/news-and-comment/news/nhs-figures-show-health-service-un-
der-considerable-strain
591 Malik, S., Muhammad, K. and Waheed, Y. (2023) ‘Emerging Applications of Nanotechnology in
Healthcare and Medicine’. Molecules, 28(18). https://doi.org/10.3390/molecules28186624
592 Siegal, S. (2023) ‘2024 Global Health Care Sector Outlook: Navigating transformation’. Deloitte.
www2.deloitte.com/content/dam/Deloitte/il/Documents/tax/global-health-care-sector-out-
look-2024.pdf
593 Malik, S., Muhammad, K. and Waheed, Y. (2023) ‘Emerging Applications of Nanotechnology in
Healthcare and Medicine’. Molecules, 28(18). https://doi.org/10.3390/molecules28186624
594 Babuska, V. et al. (2022) ‘Nanomaterials in Bone Regeneration’. Applied sciences, 12(13).
https://doi.org/10.3390/app12136793
595 Yang, F. et al. (2023) ‘The potential role of nanomedicine in the treatment of breast cancer to
overcome the obstacles of current therapies’. Frontiers in Pharmacology, 14.
https://doi.org/10.3389/fphar.2023.1143102
596 Aljabali, A.A.A., El-Tanani, M. and Tambuwala, M.M. (2024) ‘Principles of CRISPR-Cas9 tech-
nology: Advancements in genome editing and emerging trends in drug delivery’. Journal of Drug
Delivery Science and Technology, 92. https://doi.org/10.1016/j.jddst.2024.105338
597 Salthouse, D. et al. (2023) ‘Interplay between biomaterials and the immune system: Chal-
lenges and opportunities in regenerative medicine’. Acta Biomaterialia, 155: 1-18. https://doi.
org/10.1016/j.actbio.2022.11.003
598 Huang, Y. et al. (2024) ‘Nanotechnology’s frontier in combatting infectious and inflammatory
diseases: prevention and treatment’. Signal Transduction and Targeted Therapy, 9. https://doi.
org/10.1038/s41392-024-01745-z
599 Tang, W. et al. (2024) ‘Computational Nanotoxicology Models for Environmental Risk As-
sessment of Engineered Nanomaterials’. Nanomaterials, 14(2). https://doi.org/10.3390/
nano14020155
600 Smolkova, B., Dusinska, M. and Gabelova, A. (2017) ‘Nanomedicine and epigenome. Possi-
ble health risks’. Food and Chemical Toxicology, 109(1): 780-796. https://doi.org/10.1016/j.
fct.2017.07.020
601 Đorđević, S. et al. (2021) ‘Current hurdles to the translation of nanomedicines from bench to the
clinic’. Drug delivery and translational research, 12(3): 500-525. https://doi.org/10.1007/s13346-
021-01024-2
602 Thu, H.E. et al. (2023) ‘Nanotoxicity induced by nanomaterials: A review of factors affect-
ing nanotoxicity and possible adaptations’. OpenNano, 14. https://doi.org/10.1016/j.ona-
no.2023.100190
603 Akçan, R. et al. (2020) ‘Nanotoxicity: a challenge for future medicine’. Turkish Journal of Medical
Sciences, 50(4): 1180-1196. https://doi.org/10.3906/sag-1912-209
604 Thu, H.E. et al. (2023) ‘Nanotoxicity induced by nanomaterials: A review of factors affect-
ing nanotoxicity and possible adaptations’. OpenNano, 14. https://doi.org/10.1016/j.ona-
no.2023.100190
605 Vollset, S.E. et al. (2024) ‘Burden of disease scenarios for 204 countries and territories,
2022–2050: A forecasting analysis for the Global Burden of Disease Study 2021’. The Lancet,
403(10440): 2204–2256. https://doi.org/10.1016/S0140-6736(24)00685-8
606 Ferrari, A.J. et al. (2024) ‘Global incidence, prevalence, years lived with disability (YLDs),
disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and
injuries in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic
analysis for the Global Burden of Disease Study 2021’. The Lancet, 403(10440): 2133–2161.
https://doi.org/10.1016/S0140-6736(24)00757-8
307 The Global 50 (2025)
References